Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Am J Intellect Dev Disabil ; 129(3): 231-241, 2024 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-38657962

RESUMEN

Individuals with intellectual and developmental disabilities (IDD) continue to experience disparities in health and well-being despite improved provisions of person-centered care. Patient-centered outcomes research (PCOR) translates evidence into practice for meaningful outcomes. This piece describes findings from an environmental scan and stakeholder outreach to identify and prioritize opportunities to enhance IDD PCOR data infrastructure. These opportunities include developing a standardized research definition; advancing data standards for service systems; improving capture of IDD at point of care; developing standardized outcome measures; and encouraging Medicaid data use for IDD research. Within this piece, we discuss the implications of addressing data gaps for enhanced research. While the identified activities provide a path towards advancing IDD PCOR data infrastructure, collaborative efforts between government, researchers, and others are paramount.


Asunto(s)
Discapacidades del Desarrollo , Discapacidad Intelectual , Humanos , Discapacidades del Desarrollo/terapia , Discapacidad Intelectual/terapia , Evaluación del Resultado de la Atención al Paciente , Estados Unidos , Atención Dirigida al Paciente/normas
2.
Am J Intellect Dev Disabil ; 129(1): 1-9, 2024 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-38147886

RESUMEN

People with autism spectrum disorder (ASD) experience high rates of psychotropic medication utilization and barriers to psychosocial services, yet limited literature explores use of these services and the association between a mental health condition (MH) and use. Using national multipayer claims data, this study estimates a multinomial logistic regression model to discern psychotropic medication and psychosocial service use among transition age youth (TAY) with ASD (12-26 years; N = 52,083) compared to a matched cohort of those without ASD (12-26 years; N = 52,083). Approximately one-third of TAY with ASD and no MH condition receive only psychotropic medication and the likelihood of using both psychosocial services and medication is higher only when TAY with ASD have a co-occurring MH condition.


Asunto(s)
Trastorno del Espectro Autista , Humanos , Adolescente , Trastorno del Espectro Autista/tratamiento farmacológico , Trastorno del Espectro Autista/epidemiología , Trastorno del Espectro Autista/psicología , Psicotrópicos/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...